AMBROSIO MARIA RAFFAELLA | Professor page

Petrioli, R., Marrelli, D., Roviello, F., D'Ignazio, A., Torre, P., Chirra, M., et al. (2020). Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer. SURGICAL ONCOLOGY, 32, 2-7. - view more
Ambrosio, M.R., Lazzi, S., Lo Bello, G., Santi, R., Del Porro, L., de Santi, M.M., et al. (2019). MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients. HAEMATOLOGICA, 104(1), e25-e28. - view more
Granai, M., Ambrosio, M.R., Akarca, A., Mundo, L., Vergoni, F., Santi, R., et al. (2019). Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature. HAEMATOLOGICA, 104(6), e269-e273. - view more
Mundo, L., Ambrosio, M.R., Raimondi, F., Del Porro, L., Guazzo, R., Mancini, V., et al. (2019). Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases. BLOOD CANCER JOURNAL, 9(12), 91. - view more
Di Napoli, A., Remotti, D., Agostinelli, C., Ambrosio, M.R., Ascani, S., Carbone, A., et al. (2019). Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) (Virchows Archiv, (2019), 475, 4, (513-518), 10.1007/s00428-019-02637-2). VIRCHOWS ARCHIV, 475(6), 799-799. - view more

All publications